Cum sociis natoque penatibus et magnis dis parturient montes
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa.
September 8, 2017
No Comments
WHAT'S HAPPENING AT PROJECT ALS
Donec quam felis, ultricies nec
Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur
September 8, 2017
No Comments
ALS Research: Video Update from Dr. Tom Maniatis, Columbia University
Project ALS researcher Dr. Tom Maniatis, Columbia University, gives an update on ALS research.
September 4, 2017
No Comments
Drug Screening
Project ALS funds critical drug testing at Columbia University and Massachusetts General Hospital/Harvard Medical School. The Project ALS Pre-Clinical Core at Columbia is currently testing
September 4, 2017
No Comments
Studying ALS Patients
The world is closer to understanding the causes of ALS. However, the most important power source in the fight to find medicine these days is…patients
September 4, 2017
No Comments
September 4, 2017
No Comments
Ocular Motor Neurons
Project ALS funds a four-lab consortium working to understand why the motor neurons controlling the eye movement—ocular motor neurons, or OMNs—remain functional in ALS, while
September 4, 2017
No Comments
FDA Approves Edaravone: First Approved ALS Treatment in Over 20 Years
Project ALS is pleased to share that the FDA has approved the drug edaravone – the first approved ALS treatment in over 20 years. Edaravone,
May 11, 2017
No Comments
Project ALS Makes Research Headlines in 2016
Results of four recently published Project ALS studies shed new light on how ALS happens, and strategies for slowing the disease. Project ALS teams led
December 9, 2016
No Comments